1 |
10449493 |
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. |
Mutation
|
2 |
10679599 |
[Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients]. |
Mutation
|
3 |
10894274 |
Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee. |
Mutation
|
4 |
12368144 |
[Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients]. |
Mutation
|
5 |
12853747 |
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. |
Mutation
|
6 |
14760897 |
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay. |
Mutation
|
7 |
15259898 |
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir. |
Mutation
|
8 |
15339340 |
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine. |
Mutation
|
9 |
15577546 |
Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment. |
Mutation
|
10 |
16218172 |
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. |
Mutation
|
11 |
16549970 |
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. |
Mutation
|
12 |
17086064 |
A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient. |
Mutation
|
13 |
17224847 |
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients. |
Mutation
|
14 |
17506609 |
Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. |
Mutation
|
15 |
18167643 |
Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity. |
Mutation
|
16 |
18453854 |
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients. |
Mutation
|
17 |
18572746 |
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV. |
Mutation
|
18 |
18624719 |
Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters. |
Mutation
|
19 |
19098499 |
Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient. |
Mutation
|
20 |
19178592 |
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. |
Mutation
|
21 |
19301976 |
Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. |
Mutation
|
22 |
19475624 |
Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B. |
Mutation
|
23 |
19889143 |
Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. |
Mutation
|
24 |
19946588 |
Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report. |
Mutation
|
25 |
20631103 |
Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. |
Mutation
|
26 |
20648600 |
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B. |
Mutation
|
27 |
20655563 |
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing. |
Mutation
|
28 |
21671883 |
Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment. |
Mutation
|
29 |
21685546 |
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain. |
Mutation
|
30 |
21915864 |
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B. |
Mutation
|
31 |
22156858 |
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy. |
Mutation
|
32 |
22166560 |
Prevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico. |
Mutation
|
33 |
22195774 |
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa. |
Mutation
|
34 |
22422696 |
The perils of relying on anti-hepatitis B total core antibody in screening individuals infected with HIV. |
Mutation
|
35 |
22459735 |
Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape. |
Mutation
|
36 |
22592516 |
HIV and Hepatitis B coinfection among perinatally HIV-infected Thai adolescents. |
Mutation
|
37 |
22860080 |
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand. |
Mutation
|
38 |
22930502 |
Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi. |
Mutation
|
39 |
23029487 |
Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa. |
Mutation
|
40 |
23109450 |
Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. |
Mutation
|
41 |
23465393 |
Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients. |
Mutation
|
42 |
23487374 |
Prophylactic effect of antiretroviral therapy on hepatitis B virus infection. |
Mutation
|
43 |
23497042 |
Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study. |
Mutation
|
44 |
23892239 |
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. |
Mutation
|
45 |
23925707 |
Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV. |
Mutation
|
46 |
24444423 |
Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies. |
Mutation
|
47 |
24587360 |
Molecular characterization of HBV strains circulating among the treatment-naive HIV/HBV co-infected patients of eastern India. |
Mutation
|
48 |
24700252 |
HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study. |
Mutation
|
49 |
24915064 |
Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. |
Mutation
|
50 |
25449246 |
Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan. |
Mutation
|
51 |
25462190 |
Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance. |
Mutation
|
52 |
25654813 |
High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy. |
Mutation
|
53 |
25786446 |
Hepatitis B e antigen and hepatitis B surface antigen seroclearance with the emergence of lamivudine-associated and core mutations following CD4 elevation in a patient with hepatitis B and HIV. |
Mutation
|
54 |
25852125 |
Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire. |
Mutation
|
55 |
26384943 |
Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination. |
Mutation
|
56 |
26386408 |
Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy. |
Mutation
|
57 |
26390290 |
Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals. |
Mutation
|
58 |
26419862 |
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians. |
Mutation
|
59 |
26764909 |
Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon. |
Mutation
|
60 |
26890489 |
Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans. |
Mutation
|
61 |
27061406 |
Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil. |
Mutation
|
62 |
27245734 |
Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequences. |
Mutation
|
63 |
27354181 |
HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia. |
Mutation
|
64 |
27381922 |
HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg. |
Mutation
|
65 |
27769271 |
Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon. |
Mutation
|
66 |
28376292 |
Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians. |
Mutation
|
67 |
28971485 |
Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients. |
Mutation
|
68 |
29315352 |
Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. |
Mutation
|
69 |
29408943 |
Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia. |
Mutation
|
70 |
29660214 |
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa. |
Mutation
|
71 |
29948380 |
BCP/PC mutation prevalence and their association with HBV replication in HIV/HBV co-infected patients. |
Mutation
|
72 |
30257068 |
Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa. |
Mutation
|
73 |
30368502 |
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China. |
Mutation
|
74 |
30382563 |
Molecular characterization of hepatitis B virus in blood donors in Botswana. |
Mutation
|
75 |
31566576 |
High frequency of drug resistance mutations in the HBV genome in ART-experienced HIV-coinfected patients in southwestern Nigeria. |
Mutation
|
76 |
31622056 |
[Identification and molecular-genetic characteristics of the hepatitis B virus among HIV-infected patients in Arkhangelsk.] |
Mutation
|
77 |
32545313 |
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans. |
Mutation
|
78 |
32915862 |
Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia. |
Mutation
|
79 |
33245644 |
Optimization of the algorithm diagnosis chronic hepatitis B markers in patients with newly diagnosed HIV infection. |
Mutation
|
80 |
33446224 |
Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria. |
Mutation
|
81 |
33821807 |
Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study. |
Mutation
|